Buffer checks before NHS labeling
Tris and glycine consume NHS dye. BSA and gelatin require separation from the target protein; routine buffer exchange is insufficient.
Reaction pairing, buffer preparation, DOL calculations, purification and assay interpretation for AF dyes and bioconjugates.
Tris and glycine consume NHS dye. BSA and gelatin require separation from the target protein; routine buffer exchange is insufficient.
Check NHS hydrolysis and amine-containing additives, then distinguish low labeling from sample loss or reduced binding.
Calculate DOL with absorbance correction, distinguish input ratio from attached dye, and assess recovery and binding.
Cysteines may be disulfide-bound or protected. Confirm free thiols before deciding on reduction.
DTT and β-mercaptoethanol compete for maleimide; residual TCEP can also interfere.
Measure labeling density after removing free dye, then check function and changes during storage.
Use CuAAC for terminal alkynes and SPAAC for strained alkynes. Identify the handle before assessing copper compatibility.
Check reactive handles, catalyst components and copper-binding additives when conversion is low.
Use a no-handle control to distinguish labeling from adsorption, and address free dye and catalyst carryover during purification.
PEG4 and PEG12 differ in spacer length. Compare labeling, function and background at matched molar input.
Target-bound azides enable coupling; free azide reagents and sodium azide can compete for DBCO.
Use product analysis to separate low conversion from detection bias, and a no-azide control to check adsorption.
Annexin V binding requires Ca²⁺; residual EDTA or other chelators can reduce signal.
Annexin V positivity indicates accessible PS. Interpret it with membrane integrity and other apoptosis markers.
Discarding detached cells or varying collection times can change the observed Annexin V-positive fraction.
WGA labels accessible glycans. Check outline continuity for segmentation; intensity is not a direct measure of membrane amount.
WGA can be internalized by live cells. Interpret intracellular signal using timing and localization.
Fixation and permeabilization can change glycan accessibility. Compare outlines, intracellular signal and background separately.
CTB fluorescence reports GM1-associated distribution; puncta alone do not establish native lipid-raft structure.
Distinguish peripheral and intracellular CTB signals over time; one endpoint cannot establish a trafficking route.
Check conjugate-specific application data, tissue background and detection windows before assuming tracing suitability.
Free biotin occupies streptavidin-binding sites and can reduce detection of biotinylated targets.
Use unstained, streptavidin-only and non-biotinylated-probe controls to distinguish autofluorescence, endogenous biotin and adsorption.
Multivalent streptavidin can crosslink biotinylated targets, affecting live-cell motion and clustering measurements.
NHS labels primary amines; maleimide labels free thiols. Additives and reduction requirements determine sample preparation.
Terminal alkynes pair with azides through CuAAC; DBCO pairs with azides through copper-free SPAAC.
Compare labeling density, sample recovery, specific signal and background after purification, rather than total fluorescence alone.
Compare detection windows, labeling chemistry, signal intensity, photobleaching and pH response separately.
We use cookies and third-party analytics (Microsoft Clarity, Baidu Tongji, Google Analytics) to measure traffic and improve our service. Clarity includes session recording. You may decline — core site functionality is unaffected. View privacy policy